Logo image of MEHA

FUNCTIONAL BRANDS INC (MEHA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MEHA - US3609481037 - Common Stock

0.2 USD
-0.01 (-4.72%)
Last: 1/16/2026, 8:00:01 PM
0.1999 USD
0 (-0.05%)
After Hours: 1/16/2026, 8:00:01 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to MEHA. MEHA was compared to 36 industry peers in the Personal Care Products industry. Both the profitability and financial health of MEHA have multiple concerns. MEHA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year MEHA has reported negative net income.
MEHA Yearly Net Income VS EBIT VS OCF VS FCFMEHA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -500K -1M

1.2 Ratios

  • MEHA's Return On Assets of -7.56% is on the low side compared to the rest of the industry. MEHA is outperformed by 72.22% of its industry peers.
  • Looking at the Return On Equity, with a value of -365.62%, MEHA is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
ROA -7.56%
ROE -365.62%
ROIC N/A
ROA(3y)-13.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MEHA Yearly ROA, ROE, ROICMEHA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • The Gross Margin of MEHA (91.22%) is better than 100.00% of its industry peers.
  • The Profit Margin and Operating Margin are not available for MEHA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEHA Yearly Profit, Operating, Gross MarginsMEHA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 40 60 80

0

2. Health

2.1 Basic Checks

  • MEHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MEHA remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, MEHA has a worse debt to assets ratio.
MEHA Yearly Shares OutstandingMEHA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
MEHA Yearly Total Debt VS Total AssetsMEHA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • A Debt/Equity ratio of 2.26 is on the high side and indicates that MEHA has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.26, MEHA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC16.9%
MEHA Yearly LT Debt VS Equity VS FCFMEHA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -500K -1M

2.3 Liquidity

  • A Current Ratio of 0.61 indicates that MEHA may have some problems paying its short term obligations.
  • MEHA has a worse Current ratio (0.61) than 86.11% of its industry peers.
  • A Quick Ratio of 0.26 indicates that MEHA may have some problems paying its short term obligations.
  • MEHA has a Quick ratio of 0.26. This is amonst the worse of the industry: MEHA underperforms 86.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.26
MEHA Yearly Current Assets VS Current LiabilitesMEHA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.93% over the past year.
  • MEHA shows a decrease in Revenue. In the last year, the revenue decreased by -3.72%.
EPS 1Y (TTM)54.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-3.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEHA Yearly Revenue VS EstimatesMEHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

  • MEHA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEHA Price Earnings VS Forward Price EarningsMEHA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MEHA Per share dataMEHA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • MEHA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

FUNCTIONAL BRANDS INC

NASDAQ:MEHA (1/16/2026, 8:00:01 PM)

After market: 0.1999 0 (-0.05%)

0.2

-0.01 (-4.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.42%
Ins Owner Change0%
Market Cap1.41M
Revenue(TTM)6.57M
Net Income(TTM)-559.40K
AnalystsN/A
Price TargetN/A
Short Float %0.46%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 9.19
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.93
BVpS0.02
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.56%
ROE -365.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.22%
FCFM N/A
ROA(3y)-13.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.26
Altman-Z N/A
F-ScoreN/A
WACC16.9%
ROIC/WACCN/A
Cap/Depr(3y)1.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.19%
OCF growth 3YN/A
OCF growth 5YN/A

FUNCTIONAL BRANDS INC / MEHA FAQ

What is the fundamental rating for MEHA stock?

ChartMill assigns a fundamental rating of 0 / 10 to MEHA.


What is the valuation status of FUNCTIONAL BRANDS INC (MEHA) stock?

ChartMill assigns a valuation rating of 0 / 10 to FUNCTIONAL BRANDS INC (MEHA). This can be considered as Overvalued.


Can you provide the profitability details for FUNCTIONAL BRANDS INC?

FUNCTIONAL BRANDS INC (MEHA) has a profitability rating of 1 / 10.